Koers Laser Energetics, Inc. Other OTC
Aandelen
LNGT
US51805Q1022
Farmaceutische producten
Omzet 2004 | 2,5 mln. 2,32 mln. | Omzet 2005 | - | Marktkapitalisatie | 326 mln. 303 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2004 | - 0 | Nettowinst (verlies) 2005 | -1 mln. -929K | EV/omzet 2004 | - |
Nettoschuld 2004 | 3,72 mln. 3,46 mln. | Nettoschuld 2005 | 2,89 mln. 2,68 mln. | EV/omzet 2005 | - |
K/w-verhouding 2004 |
-22,6
x | K/w-verhouding 2005 |
-120
x | Werknemers | - |
Dividendrendement 2004 * |
-
| Dividendrendement 2005 |
-
| Vrij verhandelbaar | 69,19% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Battis
CEO | Chief Executive Officer | 61 | 01-11-91 |
John T. LiVecchi
CTO | Chief Tech/Sci/R&D Officer | 72 | 01-01-97 |
Dominic Battisti
AUD | Comptroller/Controller/Auditor | 68 | 01-07-92 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John T. LiVecchi
CTO | Chief Tech/Sci/R&D Officer | 72 | 01-01-97 |
Robert Battis
CEO | Chief Executive Officer | 61 | 01-11-91 |
Gregory Quarles
BRD | Director/Board Member | 63 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,09% | 6,16 mld. | |
-16,34% | 4,46 mld. | |
-7,11% | 3,27 mld. | |
+5,14% | 3,2 mld. | |
-0,18% | 2,6 mld. | |
+47,93% | 1,98 mld. | |
-7,15% | 1,7 mld. | |
+0,67% | 1,66 mld. | |
-8,73% | 1,61 mld. |